Navigation Links
Hillenbrand, Inc. Increases Quarterly Dividend to $0.185 Per Share
Date:12/5/2008

BATESVILLE, Ind., Dec. 5 /PRNewswire-FirstCall/ -- The board of directors for Hillenbrand, Inc. (NYSE: HI) has declared a regular quarterly cash dividend of $0.185 per share on the company's common stock, a 1.4 percent increase over the previous quarterly rate of $0.1825 per share. The dividend is payable Dec. 31, 2008, to shareholders of record at the close of business on Dec. 17, 2008. Hillenbrand has paid quarterly dividends since its debut as a separate public company in April 2008, beginning with its first payout in June of this year.

"The board's decision to increase the dividend reflects its confidence in the company's continued financial strength and in our future," said Kenneth A. Camp, Hillenbrand president and CEO. "Our annual dividend payout of more than $45 million, combined with our share repurchase program, reflects our commitment to return a meaningful portion of our strong cash flow to shareholders."

ABOUT HILLENBRAND, INC.

Hillenbrand, Inc. ( www.HillenbrandInc.com ) is the holding company for Batesville Casket Company, a leader in the North American death care industry through the sale of funeral services products, including burial caskets, cremation caskets, containers and urns, selection room display fixturing and other personalization and memorialization products. HI-INC-F


'/>"/>
SOURCE Hillenbrand, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Hillenbrand, Inc. Declares First Quarterly Dividend As a New Publicly Traded Company
2. Hillenbrand, Inc. Names Joe A. Raver President and Chief Operating Officer of Batesville Casket Company
3. Hillenbrand, Inc. Board of Directors Approves $100M Share Repurchase Program
4. Hillenbrand, Inc. Reports Third-Quarter Revenue of $165 Million and Earnings Per Share of $0.42
5. Hillenbrand, Inc. Announces Analyst/Investor Conference in New York Dec. 3
6. Hillenbrand, Inc. Announces Fourth-Quarter Earnings Release Date and Conference Call
7. Hillenbrand, Inc. Reports Fourth-Quarter Revenue of $159 Million and Earnings Per Share of $0.31
8. Prophylactic cranial irradiation in small cell lung cancer significantly increases survival
9. Fat on chest and upper back increases risk of insulin resistance
10. Handling Stress Properly Increases Good Cholesterol
11. High alcohol consumption increases stroke risk among Chinese men
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Comfort ... the American Cancer Society and the Road To Recovery® program to drive cancer patients ... seniors and other adults to ensure the highest quality of life and ongoing independence. ...
(Date:6/24/2016)... Georgia (PRWEB) , ... June 24, 2016 , ... ... awards today at the Clinical Decision Making in Emergency Medicine conference in Ponte ... have authored journal articles published in Emergency Medicine Practice and Pediatric ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital Partners, LLC ... by obtaining investment capital for emerging technology companies. SCP has delivered investment ... resulted in more than a million dollars of capital investment for five companies. ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... induced pluripotent stem (iPS) cells and other difficult to transfect cells, announces its ... The PluriQ™ G9™ Gene Editing System is a complete system for ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the addition of ... Forecast to 2022" report to their offering. ... date financial data derived from varied research sources to present ... impact on the market during the next five years, including ... sub markets, regional and country level analysis. The report provides ...
(Date:6/23/2016)... Research and Markets has announced the ... report to their offering. ... favourable commercial environment for MedImmune to enter. The US ageing ... serve to drive considerable growth for effective anti-influenza medications. The ... sales considerably, but development is still in its infancy. ...
(Date:6/23/2016)... 23, 2016 , , , ... 7, 2016 , , , , LOCATION: , , , ... , , , EXPERT PANELISTS:  , , , Frost & Sullivan,s ... Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program ... global pharmaceutical industry is witnessing an exceptional era. Several new demand ...
Breaking Medicine Technology: